Is there a big difference between domestic and imported drugs of enzalutamide/enzalutamide?
Enzalutamide/The original drug Enzalutamide ( Enzalutamide) is produced by Astellas and has been marketed in China and is included in the scope of medical insurance. Compared with imported drugs, domestic generic drugs are basically the same in drug ingredients, and the main differences are reflected in the manufacturer and price. The common specification of enzalutamide’s original drug is 40mg*112 tablets, and each box is priced at about 5,000 yuan, which may be a burden for some prostate cancer patients with limited financial conditions.
The price of domestic generic drugs is relatively low, usually around two thousand yuan, making it affordable for some patients. Manufacturers of generic drugs may make certain adjustments or optimizations in drug quality, but they are usually highly similar to the original drugs in terms of ingredients, dosage forms, etc., so their efficacy and safety are comparable to those of the original drugs. However, there may be certain differences in the production quality of generic drugs and the management standards of manufacturing companies, and patients should make their choice based on their doctor's advice.
From the perspective of clinical use, patients usually do not experience significant differences in effects when using original drugs and domestic drugs. The key is to decide on the most appropriate medication based on the patient's response to treatment and the professional advice of the doctor. However, due to the price advantage of domestic drugs, they usually benefit more patients, especially when reimbursed by medical insurance, which greatly reduces the cost of treatment and eases the financial burden on patients.
To sum up, the main difference between enzalutamide’s original drug and domestic generic drugs is the price. Domestic drugs are usually more affordable, but the drug ingredients and therapeutic effects are basically the same. When patients choose drugs, in addition to considering the efficacy of the drug, they should also make decisions based on their own financial situation and the guidance of their doctor.
Reference materials:https://www.xtandi.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)